U07.1 U07.2
Conditions
Interventions
Group 1: Within the framework of the tests for infection with SARS-CoV-2 ordered by health authorities or doctors, a broad-based testing of persons at risk (medical staff, contact persons, etc.) by me
e.g. medical staff), b) volunteers who have flu-like symptoms with negative SARS-CoV-2 testing and c) volunteers with positive SARS-CoV-2 testing, who are either asymptomatic, mild or severely ill. Th
mild disease: symptoms of a cold (cough, cold, fever), but at medical discretion no indication for inpatient treatment
survey at the time of the smear test
severe disease: symptoms of infection that require inpatient treatment at the time of the smear test. These patients are followed up until discharge from hospital and the clinical course is recorded (
e.g. medical staff)
Sponsors
German Cancer Research Center (DKFZ)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Subjects who receive a test for SARS- CoV-2 infection for medical or regulatory reasons. - Persons who have understood the informed consent and signed the written consent form.
Exclusion criteria
Exclusion criteria: - Rejection by the patient. - Age < 18 years. - Lack of ability to consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcome is the association of oropharyngeal microbial diversity and composition with the detection of SARS-CoV-2 in volunteers who have a medical indication for testing for this viral infection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Microbial diversity and composition in asymptomatic, mild and severe Covid-19 patients Collection of clinical data on mild vs. severe Covid-19 patients | — |
Countries
Germany
Contacts
Public ContactChristoph Stein-Thoeringer
German Cancer Research Center (DKFZ)
Outcome results
None listed